Want to see FR:ALINS full AI Analyst Report?
Intrasense SA (ALINS) AI Stock Analysis
Intrasense SA
(Paris:ALINS)
The score is primarily held down by weak financial performance—declining revenue, negative margins, ongoing losses, high leverage, and negative operating/free cash flow. Technicals add modest support in the very short term but remain broadly weak versus longer-term moving averages and negative MACD. Valuation is constrained by negative earnings (negative P/E) and no dividend yield data.
Intrasense SA (ALINS) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 10.82M
- Dividend Yield
- ―
- Average Volume (3M)
- 184.07K
- Price to Earnings (P/E)
- -0.8
- Beta (1Y)
- -0.13
- Revenue Growth
- -24.18%
- EPS Growth
- -120.44%
- Country
- France
- Employees
- 76
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Intrasense SA Business Overview & Revenue Model
Company Description
Established in 2004 and headquartered in Montpellier, France, Intrasense S.A. specializes in the global development of sophisticated software for visualizing and analyzing diverse medical imaging data, marketed under its Myrian brand. The company's o...
How the Company Makes Money
Intrasense generates revenue primarily through the sale and licensing of its software solutions to healthcare institutions, including hospitals and imaging centers. The company employs a subscription-based model for its software, which provides a rec...
Intrasense SA Financial Statement Overview
Summary
Financial statements indicate material weakness: declining revenue, negative gross and net margins, and persistent operating losses. The balance sheet shows high leverage with low equity and negative ROE, while cash flow is negative (operating and free cash flow), signaling ongoing cash burn and elevated financial risk.
Income Statement
25NegativeBalance Sheet
30NegativeCash Flow
20Very Negative| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.65M | 2.25M | 3.31M | 3.79M | 4.19M | 3.44M |
| Gross Profit | -6.07M | -3.81M | -885.00K | -1.15M | -1.05M | -454.00K |
| EBITDA | -5.37M | -4.60M | -2.68M | -2.72M | -611.00K | -217.00K |
| Net Income | -6.48M | -5.66M | -3.58M | -3.42M | -1.20M | -704.00K |
Balance Sheet | ||||||
| Total Assets | 9.19M | 7.68M | 10.45M | 6.51M | 8.77M | 6.36M |
| Cash, Cash Equivalents and Short-Term Investments | 1.44M | 930.00K | 4.55M | 1.41M | 4.76M | 2.59M |
| Total Debt | 1.37M | 1.58M | 1.49M | 2.06M | 1.93M | 2.26M |
| Total Liabilities | 10.36M | 6.03M | 3.17M | 4.50M | 3.78M | 4.21M |
| Stockholders Equity | -1.16M | 1.65M | 7.29M | 2.01M | 4.99M | 2.15M |
Cash Flow | ||||||
| Free Cash Flow | -6.50M | -5.94M | -4.97M | -3.48M | -1.50M | -1.08M |
| Operating Cash Flow | -4.62M | -3.73M | -3.05M | -2.00M | -948.00K | -481.00K |
| Investing Cash Flow | -1.86M | -2.21M | -1.93M | -1.49M | -555.00K | -551.00K |
| Financing Cash Flow | 6.61M | 2.33M | 8.10M | 98.00K | 3.62M | 2.71M |
Intrasense SA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALINS, the sentiment is Negative. The current price of 0.20 is below the 20-day moving average (MA) of 0.22, below the 50-day MA of 0.23, and below the 200-day MA of 0.23, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 43.85 is Neutral, neither overbought nor oversold. The STOCH value of 32.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALINS.
Intrasense SA Peers Comparison
Overall Rating
FR:ALCGM60Neutral
FR:ALIKO46Neutral
FR:ALTHE46Neutral
FR:ALMDT43Neutral- FR:ALINS41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| FR:ALCGM | 60Neutral | EUR 133.03M | -9.06 | -5.44% | ― | -0.98% | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| FR:ALIKO | 46Neutral | EUR 22.42M | -5.20 | -22.03% | ― | 37.28% | 7.83% |
| FR:ALTHE | 46Neutral | EUR 51.65M | -6.76 | 453.10% | ― | -16.98% | 20.31% |
| FR:ALMDT | 43Neutral | EUR 180.85M | -3.00 | 271.64% | ― | 2.16% | -5.26% |
| FR:ALINS | 41Neutral | EUR 10.82M | -0.76 | 148.60% | ― | -24.18% | -120.44% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:ALINS | Intrasense SA | 0.20 | -0.07 | -24.63% | |
| FR:ALCGM | Cegedim SA | 9.70 | -2.05 | -17.45% | |
| FR:ALTHE | Theraclion SA | 0.70 | 0.05 | 7.69% | |
| FR:ALDMS | Diagnostic Medical Systems | 0.91 | -0.41 | -30.95% | |
| FR:ALIKO | Ikonisys SA | 1.42 | -0.04 | -2.74% | |
| FR:ALMDT | Median Technologies | 3.69 | 0.79 | 27.24% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jan 15, 2026